§ 130 c Abs. 1 SGB V Nucala (R) Mepolizumab ATC-Code: R03DX09
Tender information
TED EUMünchen, Germany
- Type
- 25
- Procedure
- neg-wo-call
- Ref. number
- 792065-2024
- CPV
- 33600000
Arzneimittelrabattvertrag § 130 c Abs. 1 SGB V Arzneimittel Nucala (R), ATC-Code: R03DX09 Wirkstoff: Mepolizumab